Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2022-10-24 00:00:00 ET · period of report 2022-10-21 · accession 0001104659-22-110780 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-24 | 2022-10-21 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $0.7 | +100.0K | 11.63M | +0.9% | +$70.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.001 | 2022-10-21 | P | A | 100,000 | $0.7 | 11,625,324 | D | — | — |